Osgood-Schlatter Market Share and Top Key Player Analysis by 2023; Ossur HF, Daiichi Sankyo, Novartis AG

By , in PR PR Sports on .

Pune, India — 02/02/2018 — The Global Osgood-Schlatter Market is expected to reach USD 3.7 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.1 % during the forecast period 2017-2023.

Osgood–Schlatter disease (OSD), is inflammation of the knee and area adjacent to knee and is characterized by a painful bump just below the knee which worsens with activity. OSD is primarily the disease of growing adolescents especially experiencing growth spurts. OSD is common in those participating in sports and other physical activities especially high intensity sports such as running or jumping. OSD generally resolves with time especially with rest.

OSD affects 4% of people at least once in their lifetime and is more common in males between the ages of 10 and 15. The male to female ratio is approximately 5:1. The symptoms of OSD includes knee pain, swelling, tenderness, increased warmth under the knee and others. In extreme cases OSD may result in fracture.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/4726 .

The market drivers for global Osgood-Schlatter market are rise in adult and young population, increasing awareness and screening, development of healthcare and orthopaedic centres, rise in sports culture, growing influence of sports media, growth of physiotherapy and advancements in drugs and surgery, development of extreme sports such as mountaineering, rock climbing etc. The market restraints are the complications of treatment such as pain, bleeding, high cost of treatment, competition from alternative treatment and self-correcting nature of the disease etc.

Market development represents the best strategy for the market growth. The market is expected to witness exponential growth over the review period owing to minimal invasive surgical procedures for the treatment of fractures associated with OSD.

Product development represents the best strategy for dominating the market as the present drug treatment is fraught with side effects and is also costly. Cost of the product will be a decisive factor in the developing regions such as Asia Pacific and especially Africa. The growing demand for better and minimally invasive surgical procedures is the greatest unmet need of the market.

Check Discount @ https://www.marketresearchfuture.com/check-discount/4726 .

Global Osgood-Schlatter Market Players

Some of the key players profiled in the report are DJO Global, Inc., Teva Pharmaceutical Industries Ltd., Breg, Inc., Bayer HealthCare Pharmaceuticals LLC, Ossur HF, Daiichi Sankyo Company, Limited, Pfizer, Inc., Novartis AG, and others.

Brief TOC

Report Prologue
Market Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Osgood-Schlatter Market, by Diagnosis
Global Osgood-Schlatter Market, by Treatment
Global Osgood-Schlatter Market, by End User
Global Osgood-Schlatter Market, by Region
Company Landscape
Company Profiles
MRFR Conclusion

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/4726 .

About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

The following two tabs change content below.
Bob Allen

Bob Allen

Bob Allen is The Daily Telescope''s senior editor. He is also a nationally syndicated newspaper columnist and a bestselling author. He lives in Los Angeles and covers the intersection of money, politics and finance. He appears periodically on national television shows and has been published in (among others) The National Post, Politico, The Atlantic, Harper’s, Wired.com, Vice and Salon.com. He also has served as a journalist and consultant on documentaries for NPR and ShowTime. In 2014, he was the winner of the Society of American Business Editors and Writers' investigative journalism award, and the winner of the Izzy Award for Journalism from Ithaca College's Park Center for Independent Media. He was also a finalist for UCLA's Gerald R. Loeb Award and Syracuse University's Mirror Award. Before becoming a journalist in 2006, Sirota worked in Washington for, among others, U.S. Rep. Bernie Sanders, the U.S. House Appropriations Committee Minority Staff and the Center for American Progress.
%d bloggers like this: